Core Viewpoint - The company, 希玛医疗 (03309), announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Group 1: Share Buyback Details - The company will repurchase 120,000 shares at a total cost of HKD 20.76 million [1] - The buyback price per share ranges from HKD 1.72 to HKD 1.74 [1]

Group 1 - The company, Hema Medical (03309.HK), announced a share buyback on November 27, spending HKD 208,000 to repurchase 120,000 shares [1]

| 第一章節 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | | 證券代號 (如上市) | 03309 | 說明 | | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | | 佔有關事件前的現有已發 行股份（不包括庫存股 份）數目百分比 (註3) | 庫存股份數目 | 每股發行/出售價 (註4) | | 已發行股份總數 | | 於下列日期開始時的結存(註1) | 2025年11月26日 | | 1,238,112,870 | | 17,448,000 | | | 1,255,560,870 | | 1). 購回股份 (股份被持作庫存股份) | | | -120,000 | 0.0097 % | 120,000 HKD | | ...

Core Viewpoint - Hema Medical (03309.HK) announced a share buyback of 160,000 shares at a total cost of HKD 277,200, with a buyback price ranging from HKD 1.72 to HKD 1.74 per share [1] Company Summary - As of November 26, 2025, Hema Medical's stock closed at HKD 1.74, reflecting a 0.58% increase with a trading volume of 320,000 shares and a turnover of HKD 553,000 [1] - The market capitalization of Hema Medical is HKD 2.142 billion, ranking 15th in the medical services sector [1] Financial Metrics - Return on Equity (ROE): -6.36%, compared to the industry average of -0.02%, ranking 39th in the sector [1] - Market Capitalization: HKD 2.142 billion, while the industry average is HKD 7.938 billion, ranking 15th [1] - Revenue: HKD 1.935 billion, with the industry average at HKD 3.832 billion, ranking 15th [1] - Net Profit Margin: 5.95%, significantly better than the industry average of -843.36%, ranking 25th [1] - Gross Profit Margin: 31.12%, compared to the industry average of 39.76%, ranking 28th [1] - Debt Ratio: 29.8%, much lower than the industry average of 74.15%, ranking 21st [1]

Core Viewpoint - The company, XiMa Medical (03309), announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Group 1: Share Buyback Details - The company plans to repurchase 160,000 shares at a total cost of HKD 277,200 [1] - The buyback price per share ranges from HKD 1.72 to HKD 1.74 [1]

Core Viewpoint - The company, Hema Medical (03309), announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Group 1 - The company will repurchase 160,000 shares at a total cost of HKD 277,200 [1] - The buyback price per share ranges from HKD 1.72 to HKD 1.74 [1] - The buyback is scheduled to take place on November 26, 2025 [1]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 希瑪醫療控股有限公司 呈交日期： 2025年11月26日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | | 證券代號 (如上市) | 03309 | 說明 | | | | | | | | A. 已發行股份或庫存股份變動 | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | | 事件 | | | 佔有關事件前的現有已發 | | | 每股發行/出售價 ...

Core Viewpoint - The company, Hema Medical (03309), announced a share buyback plan, indicating confidence in its financial position and future prospects [1] Group 1 - The company will spend HKD 344,000 to repurchase 200,000 shares [1]

Group 1 - The company, XiMa Medical (03309), announced a share buyback plan to repurchase 200,000 shares at a cost of HKD 344,000 [1]

Core Viewpoint - Hema Medical (03309.HK) announced a share buyback of 200,000 shares at a cost of HKD 344,000 on November 25 [1] Group 1 - The company is actively engaging in share repurchase to potentially enhance shareholder value [1] - The buyback reflects the company's confidence in its financial position and future prospects [1]